pan 14-3-3 Rabbit pAb
Applications | WB |
Reactivities | Mouse, Rat, Human, Monkey |
pan 14-3-3 Rabbit pAb
Applications | WB |
Reactivities | Mouse, Rat, Human, Monkey |
Mouse Monoclonal cIAP2 Antibody
Applications | WB |
Reactivities | Human, Monkey |
Mouse Monoclonal c-Fos Antibody
Applications | WB |
Reactivities | Human, Rat, Monkey |
Mouse Monoclonal Annexin A1 Antibody
Applications | WB |
Reactivities | Human, Monkey, Mouse, Rat |
TRIM38 mouse monoclonal antibody, clone OTI15H4 (formerly 15H4)
Applications | IF, WB |
Reactivities | Human, Monkey, Mouse |
ZFP36 mouse monoclonal antibody, clone OTI1G9 (formerly 1G9)
Applications | FC, WB |
Reactivities | Human, Dog, Monkey, Mouse, Rat |
SCFD1 mouse monoclonal antibody, clone OTI2B7 (formerly 2B7)
Applications | IHC, WB |
Reactivities | Human, Dog, Rat, Monkey, Mouse |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
CD71 (TFRC) mouse monoclonal antibody, clone DF1513, Low Endotoxin
Applications | FC |
Reactivities | Human, Monkey |
Mouse Monoclonal Rad51 Antibody
Applications | WB |
Reactivities | Human, Mouse, Rat, Monkey |
Mouse Monoclonal STAT3 Antibody
Applications | WB |
Reactivities | Human, Mouse, Rat, Hamster, Monkey |
Anti-BCMA [I09], Mouse IgG1, kappa
Applications | FC |
Reactivities | Human, Monkey |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-CD3 [CD3B219], Rabbit IgG, lambda
Applications | FC |
Reactivities | Human, Monkey |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format for improved compatibility with existing reagents assays and techniques. |
Anti-BCMA [I09], Rabbit IgG, kappa
Applications | FC |
Reactivities | Human, Monkey |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. |